Product NDC: | 0069-5820 |
Proprietary Name: | Tikosyn |
Non Proprietary Name: | dofetilide |
Active Ingredient(s): | .5 mg/1 & nbsp; dofetilide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-5820 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020931 |
Marketing Category: | NDA |
Start Marketing Date: | 19991001 |
Package NDC: | 0069-5820-43 |
Package Description: | 40 CAPSULE in 1 BOTTLE, UNIT-DOSE (0069-5820-43) |
NDC Code | 0069-5820-43 |
Proprietary Name | Tikosyn |
Package Description | 40 CAPSULE in 1 BOTTLE, UNIT-DOSE (0069-5820-43) |
Product NDC | 0069-5820 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dofetilide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19991001 |
Marketing Category Name | NDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | DOFETILIDE |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiarrhythmic [EPC] |